USPTO serial 90394086
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Santa Monica, CA
Santa Monica, CA
Santa Monica, CA
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
JOHN PAUL OLEKSIUK
JOHN PAUL OLEKSIUK COOLEY LLP1299 PENNSYLVANIA AVENUE NW SUITE 700WASHINGTON, DC 20004UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Antihistamines; Antihistamine blockers; Non-sedating antihistamines; Intra-nasal steroids; bronchodilators; Steroids; Laxatives; Probiotics; Acid reducer; Antacid; Caffeine; Caffeine preparations for stimulative use; Highly caffeinated energy pills; Caffeine preparation for stimulative use in the form of chewing gum; H2 blocker; Proton pump inhibitor; Diphenhydramine; Doxylamine; Melatonin; Nicotine gum for use as an aid to stop smoking; Nicotine patches for use as aids to stop smoking; Nicotine for nicotine replacement therapy; Smoking cessation preparations; Oral spray for cessation of smoking; Transdermal patches featuring smoking cessation preparations; Therapeutic preparations for treating muscle soreness; Topical pain relief products; Medicaments for promoting recovery from tendon and muscle injuries and disorders and sports related injuries Multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; Analgesic and muscle relaxant pharmaceutical preparations; Topical analgesic creams; Analgesic balm; Analgesic preparations; Topical analgesics; Antipyretic analgesics; Analgesics; Anti-inflammatory salves; Anti-inflammatory gels; Homeopathic anti-inflammatory ointment; Anti-inflammatory and antipyretic preparations; Anti-inflammatory ointments; Anti-inflammatories; Anti-inflammatory sprays; Sports cream for relief of pain; Ibuprofen for use as an oral analgesic; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Oral analgesics; Cough pastilles for medical use; Non-medicated topical gel for the prevention and treatment of cold and flu; Pharmaceutical antitussive-cold preparations; Preparations for treating colds; Anti-cough drop; Cough treatment preparations; Cough syrups; Cough lozenges; Cough expectorants; Cough drops; Medicines, remedies and preparations, namely, antitussive cold preparations, preparations for treating colds, cough treatment preparations in the nature of cough suppressants, cough syrups; cold capsules; flu medicine; day and night cold medicine; pain relievers, namely, aspirin and non-aspirin; sore throat lozenges; external medication for the relief of cold symptoms; pain relief medication; Acetaminophen for relief of pain; Throat powder for the relief of sore throat pain; Preparation for the relief of pain | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 10, 2023 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 10, 2023 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 6, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 28, 2022 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Jul 28, 2022 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Jul 28, 2022 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Mar 9, 2022 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Mar 9, 2022 | OPPF | OPPOSITION PAPERS RECEIVED AT TTAB | — |
| Feb 8, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 8, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 19, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 4, 2022 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 4, 2022 | ALIE | ASSIGNED TO LIE | — |
| Jan 3, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 6, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 6, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 6, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 28, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 28, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 28, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 15, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 15, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 15, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 15, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 14, 2021 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 17, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 12, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 3, 2021 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Mar 2, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 22, 2020 | NWAP | NEW APPLICATION ENTERED | — |